Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma

Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.

644 public trials 152 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma trial results

Completed

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

NCT02336165

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Research Facility Los Angeles, California, United States
  • Research Facility San Francisco, California, United States
  • Research Facility Baltimore, Maryland, United States
  • Research Facility Boston, Massachusetts, United States
View Trial Details
Completed

Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors

NCT01609790

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
View all 244 locations
View Trial Details
Completed

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

NCT02968940

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center New York, United States
View Trial Details
Completed

Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab

NCT02330562

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • University of Californai, Irvine Orange, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
  • Weill Cornell Medical College New York, United States
  • Duke Univ Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions